TSHA position history
The shares of Taysha Gene Therapies (TSHA) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 156,586 shares, $861K, <0.01% of portfolio, New
- 2026 Q1: 319,748 shares, $1.4M, <0.01% of portfolio, Add +104.2%
- 2026 Q2: 489,219 shares, $3.3M, 0.03% of portfolio, Add +53.0%
- 2026 Q3: 503,379 shares, $2.5M, 0.03% of portfolio, Add +2.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|